UiPath PATH 深 沪
交易中 11-21 10:13:26 美东时间
12.62
-0.110
-0.86%
华盛通- 最 高12.88
- 今 开12.82
- 成交量 214.48万股
- 最 低 12.58
- 昨 收 12.73
- 总市值 67.01亿
- 52周最高 18.74
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 9.38
- 委 比 -98.13%
- 总股本 5.31亿
- 历史最高 90.00
- 量 比 2.08
- 振 幅 2.36%
- 历史最低 9.38
- 每 手 1
- 风险率 1.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Comparing Microsoft With Industry Competitors In Software Industry
In today's fast-paced and competitive business landscape, it is essential for i...
13分钟前
CFRA upgrades UiPath (PATH) to a Buy
UiPath received a Buy rating and price target from CFRA analyst on November 14....
11-17 21:46
SA Asks: What are the best robotics stocks right now?
What are the best robotics stocks right now for investors? Seeking Alpha analysts Michael Del Monte and Julia Ostian offer their picks. Michael Del Monte: Ametek (AME) remains a top pick for robotics ...
11-17 05:01
Driving ROI With Azure AI Foundry And UiPath: Intelligent Agents In Real-World Healthcare Workflows
https://azure.microsoft.com/en-us/blog/driving-roi-with-azure-ai-foundry-and-uipath-intelligent-agents-in-real-world-healthcare-workflows/
11-06 02:32
股价暴涨近50%！UiPath带火的“智能体自动化”，艺赛旗已摸到新玩法
（来源：蚌埠新闻网） 转自：蚌埠新闻网 当UiPath的股价在两周内飙升近50%，创四个月新高时，整个科技圈都在追问：这家全球RPA（机器人流程自动化）巨头，凭...
10-31 17:32
Chewy to acquire equine health provider SmartPak, reaffirms Q3 guidance
Chewy (CHWY) has agreed to acquire equine health products provider, SmartPak Equine from Covectrus for an undisclosed amount. The all-cash deal is expected to be financed through Chewy’s (CHWY) existi...
10-30 23:34
UiPath Achieves ISO/IEC 42001 Certification For AI Management Systems
UiPath (NYSE:PATH), a global leader in agentic automation, today announced that it has achieved ISO/IEC 42001:2023 certification, the world's first international standard for Artificial Intelligence Management Systems
10-27 20:29
Analyzing Microsoft In Comparison To Competitors In Software Industry
In today's fast-paced and competitive business landscape, it is essential for i...
10-24 23:00
美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
10-24 09:51
